ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 126 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $261,516 | -8.1% | 176,700 | 0.0% | 0.00% | – |
Q2 2023 | $284,487 | -17.5% | 176,700 | +48.7% | 0.00% | – |
Q1 2023 | $344,636 | -12.2% | 118,840 | -0.7% | 0.00% | – |
Q4 2022 | $392,419 | -3.1% | 119,640 | +11.8% | 0.00% | – |
Q3 2022 | $405,000 | -30.3% | 107,040 | +43.4% | 0.00% | – |
Q2 2022 | $581,000 | -15.3% | 74,640 | +1.1% | 0.00% | – |
Q1 2022 | $686,000 | -40.9% | 73,840 | +0.3% | 0.00% | – |
Q4 2021 | $1,161,000 | -13.9% | 73,640 | -2.3% | 0.00% | -100.0% |
Q3 2021 | $1,349,000 | +6.9% | 75,340 | -7.1% | 0.00% | 0.0% |
Q2 2021 | $1,262,000 | +8.3% | 81,140 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,165,000 | -24.6% | 81,140 | +3.0% | 0.00% | 0.0% |
Q4 2020 | $1,546,000 | +51.6% | 78,740 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,020,000 | +0.7% | 78,740 | +13.2% | 0.00% | 0.0% |
Q2 2020 | $1,013,000 | +89.0% | 69,540 | +10.5% | 0.00% | – |
Q1 2020 | $536,000 | -40.4% | 62,940 | +15.2% | 0.00% | -100.0% |
Q4 2019 | $900,000 | +16.6% | 54,640 | 0.0% | 0.00% | – |
Q3 2019 | $772,000 | -29.8% | 54,640 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $1,099,000 | -49.4% | 54,640 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $2,172,000 | +14.4% | 54,640 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $1,898,000 | -16.0% | 54,640 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $2,259,000 | +12.5% | 54,640 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,008,000 | +78.5% | 54,640 | +89.5% | 0.00% | 0.0% |
Q1 2018 | $1,125,000 | +124.1% | 28,840 | +4.0% | 0.00% | – |
Q4 2017 | $502,000 | +9.4% | 27,740 | 0.0% | 0.00% | – |
Q3 2017 | $459,000 | +18.3% | 27,740 | 0.0% | 0.00% | – |
Q2 2017 | $388,000 | +1.8% | 27,740 | +49.6% | 0.00% | – |
Q1 2017 | $381,000 | +27.4% | 18,540 | -11.9% | 0.00% | – |
Q4 2016 | $299,000 | -33.6% | 21,040 | 0.0% | 0.00% | – |
Q3 2016 | $450,000 | -12.8% | 21,040 | -8.3% | 0.00% | – |
Q2 2016 | $516,000 | +45.4% | 22,940 | +23.1% | 0.00% | – |
Q1 2016 | $355,000 | -37.3% | 18,640 | -13.1% | 0.00% | – |
Q4 2015 | $566,000 | -16.0% | 21,440 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $674,000 | -40.6% | 21,440 | -0.3% | 0.00% | 0.0% |
Q2 2015 | $1,134,000 | +346.5% | 21,500 | +252.5% | 0.00% | – |
Q1 2015 | $254,000 | – | 6,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |